Skip to content
‹ Back to IndustriesHealthcare

Weight-Bearing CT’s Role in Assessing Pes Cavovarus

Dr. Alessio Bernasconi, MD, FEBOT and  his colleagues at the Royal National Orthopaedic Hospital in London have produced critical and salient findings about the role of weight-bearing CT imaging (WBCT) in assessing pes cavovarus. Dr. Bernasconi recently shared these findings in a FOOTinnovate webinar, and his presentation is outlined below. Click here to watch the FOOTInnovate…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Dr. Alessio Bernasconi, MD, FEBOT and his colleagues at the Royal National Orthopaedic Hospital in London have produced critical and salient findings about the role of weight-bearing CT imaging (WBCT) in assessing pes cavovarus.

Dr. Bernasconi recently shared these findings in a FOOTinnovate webinar, and his presentation is outlined below.

Click here to watch the FOOTInnovate webinar. A FOOTInnovate account is required.

A Refresher on Pes Cavovarus Diagnosing Procedures

Pes cavovarus is considered a three-dimensional deformity and is characterized by a high-arched, varus hindfoot alignment with a forefoot that may be abducted or plantarflexed depending on the individual case.

Diagnostic work for pes cavovarus is based on a thorough clinical assessment. However, additional imaging is needed, and X-Ray imaging is the current standard. Additional CT or MRI imaging can be ordered to further characterize the deformity and assess the status of joints and soft tissues.

However, common dorsoplantar, lateral views of bilateral cavovarus deformity can bring along with them difficulty in precisely identifying joint planes and status. Recent studies, including published papers from PubMed suggest that radiographs have inherent bias as beam position, operators, foot position, and more can change what doctors see and identify.

Is there any objective way to identify hindfoot alignment?

Improving Identification of Hindfoot Alignment

The Saltzman view – developed by Charles Saltzman, MD and Georges El-Khoury, MD – is designed to find the main axis of the tibia and the main axis of the calcaneus, then to define the angle between those two lines.

However, this view can still be limited by rotation of the foot.

That’s why authors like Jonathan Kaplan, MD, who outlined a solution in Foot & Ankle International, propose the use of weight-bearing CT scanning as a better alternative when diagnosing malalignment associated with pes cavovarus.

The Implications of Weight-Bearing CT Scanning

Two studies published in 2017 and 2018 introduced the idea of using three-dimensional measurements on weight-bearing CT images, allowing the measurement of malalignment to move away from a single plane and toward a volume-based view that produces a more reliable and true view of the bones in physical space.

The three measurements proposed are foot and ankle offsets, the calcaneal offset and the hindfoot alignment angle.

In 2017, a study assessing 135 datasets including normally aligned feet, varus hindfeet and valgus hindfeet demonstrated excellent inter and intra-observer reliability using this new measurement.

The true revolution in utilizing 3D measurements is that, in gathering the three measurements, you can add a fourth point to represent volume that provides that additional beneficial depth.

“What you need is a cone-beam, weight-bearing CT device,” Dr. Bernasconi said. “In our institution, we use the PedCAT one. You need a software to elaborate data – CubeVue – and you need a TALAS plug-in.”

Essentially, Dr. Bernasconi said, this landmark software solution can provide a simpler way to obtain values relative to the normative values that highlight varus or valgus malalignment.

Critical Questions

Dr. Bernasconi highlighted three critical questions regarding the reliability of this new solution:

  • How reliable are 3D measurements when diagnosing pes cavovarus?
  • Does etiology affect reliability?
  • Does the severity of the deformity affect reliability?

To find the answers, Dr. Bernasconi and the staff at the Royal National Orthopaedic Hospital completed a retrospective study based on STROBE guidelines of patients with a pes cavovarus diagnosis from their hospital between 2015 and 2017.

Eventually settling on 17 patients, the team matched those patients with an equal number of normally aligned feet. Three observers with different levels of expertise and different knowledge of the weight-bearing CT imaging process produced excellent inter-observer reliability. Further, there was little variance between the observers, suggesting that the data is reliable regardless of previous expertise, etiology and deformity severity.

“The reason that we have studied foot morphology, thanks to the help, obviously, of this new technology, (is that) standing CT allows you to reproduce in a more faithful way the true geometry of the bone and the joints in the space,” Dr. Bernasconi said. “We think that this may potentially help us better understand the etiology.”

Though Dr. Bernasconi said his findings were far from enough to fully corroborate this positive outcome, they are certainly a starting point.

The takeaway, he said, is that this new, 3D approach will allow for reliable assessment of pes cavovarus, both in the diagnosing stage and in monitoring patients after procedures to determine how successful the correction was.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

AI cuts cardiologists' echocardiogram review time by 46%

AI cuts cardiologists' echocardiogram review time by 46%

Late-breaking research presented November 9 at the American Heart Association's Scientific Sessions 2026 reported that AI-drafted preliminary echocardiogram reports were comparable to human drafts. Cardiologists averaged 4.6 minutes finalizing AI drafts versus 8.5 minutes without AI. The findings are a non-peer-reviewed abstract.

  • 01Cardiologists averaged 4.6 minutes finalizing AI-drafted echo reports versus 8.5 minutes without AI, about 46% less time.
  • 02Cardiologists made substantial changes to 50.6% of AI drafts and 49.7% of human drafts.
  • 03The research used 1,200 echocardiograms from 21 Kaiser Permanente Northern California medical centers.

Nov 9, 2026

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Access TeleCare pharmacist Ashley Selby describes a telehealth antimicrobial stewardship model sized to each hospital's gaps. Joint Commission Standard MM.09.01.01 and 42 CFR 482.42 require a qualified physician and/or pharmacist leader, not a full-time hire, and a 14-study meta-analysis found telehealth stewardship cut antibiotic days of therapy without changing mortality.

  • 01Joint Commission Standard MM.09.01.01, in force since January 2023, requires a physician and/or pharmacist qualified in infectious diseases or stewardship to lead the program, and its committee note allows remote participation.
  • 02The Board of Pharmacy Specialties counts more than 2,380 BCIDP pharmacists nationally, while many small hospitals still assign stewardship to pharmacists without ID training.
  • 03A 14-study meta-analysis found telehealth stewardship raised guideline adherence and cut antibiotic days of therapy, but did not significantly change mortality.

Nov 9, 2026

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512